BioPlus Acquisition Corp. Warrants
BIOSW
BIOSW was delisted on the 6th of October, 2023.
44 hedge funds and large institutions have $1.33M invested in BioPlus Acquisition Corp. Warrants in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
2% more funds holding
Funds holding: 43 → 44 (+1)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
76% less capital invested
Capital invested by funds: $5.67M → $1.33M (-$4.34M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$33.3K |
| 2 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
+$20.7K |
| 3 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$10.3K |
| 4 |
Walleye Capital
New York
|
+$6.62K |
| 5 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$5.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$3.56M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$6.43K |
| 3 |
KL
KIM LLC
Wichita,
Kansas
|
-$3.13K |
| 4 |
CS
Clear Street
New York
|
-$1.31K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$952 |
BIOSW Hedge Fund Activity: Q2 2023 in Review
44 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Warrants (BIOSW) for Q2 2023, worth a combined $1.33M — down 76% from $5.67M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BIOSW positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 7 trimmed.
The largest buyer was Cowen and Company, adding an estimated $33.3K. The largest seller was Mangrove Partners, exiting entirely with an estimated $3.56M sold.
- 44 institutional investors held BioPlus Acquisition Corp. Warrants (BIOSW) as of Q2 2023, up from 43 in Q1 2023.
- Funds reported $1.33M of BioPlus Acquisition Corp. Warrants stock for Q2 2023, down 76% quarter-over-quarter.
- 4 funds opened new BioPlus Acquisition Corp. Warrants positions in Q2 2023 and 2 closed out, a net change of +2 holders.
- The largest BioPlus Acquisition Corp. Warrants buyer in Q2 2023 was Cowen and Company, an estimated $33.3K added.
- The largest BioPlus Acquisition Corp. Warrants seller in Q2 2023 was Mangrove Partners, an estimated $3.56M sold.
Based on aggregated 13F filings for Q2 2023.